Mycoplasma pneumoniae in the post COVID-19 era: Diagnostic challenges and rising macrolide.. @Labroots
Mycoplasma pneumoniae in the post COVID-19 era: Diagnostic challenges and rising macrolide..  @Labroots
Uploaded December 2025 | Updated November 2026, 5 hours ago
Presented By: Huanyu Wang PhD, D(ABMM)



Speaker Biography: As the Assistant Director of Clinical Microbiology and Immunoserology, Huanyu Wang, PhD, focuses on research and development for new methodologies and providing mentorship and technical support to the clinical fellows in infectious disease. She also provides technical oversight in the area of molecular infectious disease testing, participates in quality control and quality improvement initiatives.

Dr. Wang earned her Ph.D. in Molecular Biology and Biochemistry from The Ohio State University and a Bachelor of Medicine from Peking University, Health Science Center, China. She is certified by the American Society of Clinical Pathology as a Specialist in Microbiology and a Technologist in Molecular Biology.



Webinar: Mycoplasma pneumoniae in the post COVID-19 era: Diagnostic challenges and rising macrolide resistance



Webinar Abstract: Mycoplasma pneumoniae(MPN) is a major pathogen of community-acquired respiratory tract infections in school-age children with cyclic epidemics occurring every few years. Circulation of this pathogen declined sharply during the COVID-19 pandemic but has re-emerged in many regions since 2023. Macrolides are the drugs of choice for treatment of MPN infections. While macrolide resistance in MPN exceeds 90% in Eastern Asia, it remains low in the U.S. prior to the COVID-19.

This presentation will discuss the epidemiologic trends associated with post-pandemic resurgence of MPN, review current diagnostic strategies for MPN infections, and summarize treatment considerations and emerging data on macrolide resistance in the post–COVID-19 era.

Learning Objectives:

1. Describe Mycoplasma pneumoniae, the epidemiology and clinical presentation of M. pneumoniae infection

2. Review the laboratory diagnostic approaches for M. pneumoniae infections

3. Discuss treatment and macrolide resistance



Earn PACE Credits: 1. Make sure you’re a registered member of Labroots (labroots.com/virtual-event/clinical-diagnostics-research-2025/agenda) 2. Watch the webinar on YouTube or on the Labroots Website (labroots.com/virtual-event/clinical-diagnostics-research-2025/agenda) 3. Click Here to get your PACE credits (Expiration date –11/12/2026): (labroots.com/virtual-event/clinical-diagnostics-research-2025/continuing-education-credits) This link will be located in the CMS in the webinar CE tab – please enable third party PACE link



Labroots on Social:
Facebook: facebook.com/LabRootsInc
Twitter: twitter.com/LabRoots
LinkedIn: linkedin.com/company/labroots
Instagram: instagram.com/labrootsinc
Pinterest: pinterest.com/labroots
SnapChat: labroots_inc
Mycoplasma pneumoniae in the post COVID-19 era: Diagnostic challenges and rising macrolide..Keynote Presentation: Selecting Targeted Cancer Therapies and Clinical Trials with Computational...Human-on-a-Chip for Translational PK/PD and Disease Modeling: Cardiac Ischemia, a Patient...Precision in Practice: Managing Indeterminate TB Testing with Quality SystemsUnlock Cell Therapy Potential with Customizable Cell Isolation and Enhanced T cell Activation...Lessons from the Classroom Using ELNs to Train the Next Generation of ScientistsMicrobiology of barrier components of a deep geological repository for used nuclear fuelClosing the Gap: Barriers to Diabetes Diagnosis in Real-World PracticeCombined JAK Inhibition and PD-1 blockade Improves Response in Lung Cancer PatientsBehind the Scenes: New HPLC Performance EnhancementsOpening - Proteomics to advance precision healthGynecologic Prognostic and Predictive Markers in the Era of Precision Medicine
Labroots |

Mycoplasma pneumoniae in the post COVID-19 era: Diagnostic challenges and rising macrolide..

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER